US-based contract development and manufacturing organisation (CDMO) INCOG BioPharma has announced a new $125m investment to expand its sterile injectables production capacity.
The expansion includes building a second, 100,000ft2 manufacturing facility on its campus in Fishers, Indiana, with construction set to begin next month.
INCOG said that the new facility will enhance its capacity for the assembly of autoinjectors, pens, wearable injectors, and syringe accessories, along with labelling and final packaging.
With the expanded manufacturing, the company is enabled to provide comprehensive, end-to-end solutions from filling through device assembly to final packaging.
In addition, the expansion will create more than 100 additional high-paying jobs, further establishing Fishers, and the state of Indiana, in biopharmaceutical manufacturing, said INCOG.
INCOG CEO and founder Cory Lewis said: “Our customers will have access to a suite of solutions from filling through final packaging.
“This supply chain integration is essential in accelerating a drug product to commercial launch, and even more important in today’s constrained markets as the need for sterile injectable products is quickly growing to address challenging diseases and improve healthcare outcomes.
“The hard work and expertise of the team we have built at INCOG has allowed us to accelerate investments and address the immediate needs of the global biopharma industry.”
The company’s decision on expansion closely follows its ongoing work on installing a second high-speed syringe and cartridge filling line with automated visual inspection equipment.
Its new filling line will complement the existing multi-use filling line, bringing the site’s total filling capacity to 140 million units per annum.
The automated visual inspection and autoinjector assembly capabilities are currently accessible, with the additional syringe filling capacity to come online in the second quarter of 2025.
INCOG said that the enhancements will further enable the company to meet the growing demand for biopharmaceutical solutions that use pre-filled syringes and autoinjectors.
Furthermore, the Indiana Economic Development Corporation (IEDC) and the City of Fishers helped the company in obtaining the necessary funding for the expansion project.
Fishers Mayor Scott Fadness said: “We are incredibly proud to witness INCOG’s growth and expansion into a second building. This expansion reinforces Fishers as a leading hub for life sciences and biopharma manufacturing.
Lewis added: “We are proud to contribute to the social and economic growth of Fishers, by creating new jobs and fostering a vibrant life science community. “The city and IEDC have served as an extension of our team. It’s exciting to bring current and prospective clients to our facility so they can experience the growing community where we do business.”
